WESTBURY... NY–(Marketwired – Nov 12... 2014) – Vasomedical... Inc. (“Vasomedical”) (OTCBB: VASO) today reported its operating results for the three months ended September 30... 2014. “We are pleased to report that during the third quarter of 2014 revenue from our Sales Representation segment increased 9.3% to $6.4 million compared to the same period in 2013...
Read More

Management to hold investor conference call on November 12th at 10:00 a.m. ET WESTBURY, NY / ACCESSWIRE /November 5, 2014 / Vasomedical, Inc. (VASO) announced today that it will release its financial results for the three months ended September 30th, 2014 on Wednesday, November 12th, 2014, before markets open. The Company will host a conference...
Read More

Vasomedical to Market and Sell EECP Therapy, BIOX ECG Holter and Ambulatory Blood Pressure Monitoring Products in Brazil WESTBURY, N.Y. / ACCESSWIRE / September 2, 2014 / Vasomedical, Inc.(“Vasomedical” or “The Company”) (OTCBB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology including EECP(R) Therapy...
Read More

WESTBURY, NY–(Marketwired – Aug 13, 2014) – Vasomedical, Inc... (“Vasomedical”) (OTCBB: VASO) today reported its operating results for the three months ended June 30, 2014... “We are pleased to report that during the second quarter of 2014 revenue from our Sales Representation Segment increased 4...6% to $6...7 million compared to the same period in 2013...
Read More

WESTBURY, NY / AUGUST 6, 2014 / ACCESSWIRE / Vasomedical, Inc. (OTCBB: VASO) announced today that it will release its financial results for the three months ended June 30, 2014 on Wednesday, August 13, 2014, before markets open. The Company will host a conference call on Wednesday, August 13th at 10:00 a.m. ET featuring remarks by Jun...
Read More